|Bid price||36.00||Open price||37.50|
|Ask price||39.00||Prev close||37.50|
Register now for FREE live Cathay International Holdings share prices, Cathay International Holdings stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Cathay International Holdings Level 2 Data, indepth research tools and investor commentary for Cathay International Holdings (CTI) and other London Stock Exchange equities.
Register now for FREE Cathay International Holdings share price charts
|Name||Cathay International Holdings||Epic||CTI|
|Sector||Real Estate Investment & Services||ISIN||BMG1965E1030|
|Activites||Cathay International Holdings Limited (CIH), focused on the People's Republic of China (PRC), is an investment holding company and a leading investor in the growing healthcare sector in China. The Group employs more than 2000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's headquarters in Hong Kong and Shenzhen. CIH aims to identify investment opportunities with emphasis on high growth healthcare markets and build them into market sector leaders, with a clear exit strategy. The Group has demonstrated a strong track record of identifying high-growth potential investment opportunities in this area including: Lansen Group, a leading specialty pharmaceutical company focused on rheumatology and Haotian Group, a company engaged in the manufacture, marketing and sale of key active ingredients for healthcare products, including inositol. To complement its healthcare portfolio, CIH has an R&D business focused on bringing new products to the growing Chinese market. The Group also has a private equity investment arm focused on minority investment opportunities and a hotel investment.||Index||n/a|
|Latest Share Price (p)||37.50||Net Gearing (%)||50.22|
|Market Capitalisation (£m)||137.94||Gross Gearing (%)||54.26|
|Shares in issue (m)||367.85||Debt Ratio||30.16|
|P/E Ratio||-22.87||Debt-to-Equity Ratio||0.36|
|Total dividends per share (p)||0.00||Assets / Equity Ratio||2.19|
|Dividend Yield (%)||0.00||Price to book value||0.72|
|Dividend cover (x)||0.00||ROCE||0.02|
|Earning per share (p)||-1.64||EPS Growth (%)||8.38|
|52 week high / low||41.00 / 27.50||DPS Growth (%)||n/a|
Cathay International Holdings - a leading investor in the growing healthcare sector in China - has granted 7,390,353 options under to members of the group's management and employees. These include 4,142,353 options to chief executive Lee Jin-Yi; 760,000 to finance director Eric Siu Ka Chi;...
/* */ RNS Number : 1916E Cathay International Holdings Ld 07 April 2014 Cathay International Holdings Limited ("Cathay" or the "Company") Grant of Share Options Hong Kong, 7 April 2014 - Cathay International Holdings Ltd. (LSE:...
Cathay International's 50.56%-held subsidiary Lansen Pharmaceutical has acquired the pharmaceutical product, marketed and sold in China by Novartis under the Sicorten Plus brand. Sicorten Plus is used for certain types of skin disease, known as inflammatory skin disease specifically for...
Register now for FREE Cathay International Holdings company news
No Cathay International Holdings Share Price Discussions
Register now for FREE Cathay International Holdings share price discussions